• leader board size
Case Studies2020-11-19T22:10:23-08:00

Case Studies

Cronos Group Inc Reports Q2 2025 Financial Results

TORONTO – Cronos Group Inc., a Canadian cannabinoid company with an international outreach, reported its Q2 2025 financial results, showcasing a 21% year-over-year increase in net revenue, reaching $33.5 million. The growth was primarily driven ...

Cresco Labs Reports Q2 2025 Financial Results

CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...

Legal Status of Cannabis in Europe

LOS ANGELES- A growing number of European countries now permit the use, cultivation or sale of cannabis under regulated conditions, driven by evolving public policy and emerging economic opportunity. Germany legalized limited recreational use on ...

Cronos Group Inc Reports Q2 2025 Financial Results

TORONTO – Cronos Group Inc., a Canadian cannabinoid company with an international outreach, reported its Q2 2025 financial results, showcasing a 21% year-over-year increase in net revenue, reaching $33.5 million. The growth was primarily driven ...

Cresco Labs Reports Q2 2025 Financial Results

CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...

Organigram Reports Q3 Fiscal 2023

LOS ANGELES- Organigram Holdings Inc. a licensed producer of cannabis, today unveiled its financial outcomes for the third quarter ending May 31, 2023. The period was marked by remarkable resilience and growth in the company’s ...

Subscribe To Our Newsletter

Go to Top